Press Release Archive

Advances in Molecular Testing Offer New Hope for Lung Cancer Patients

Report to AMA documents the challenges, related technology, and proposed coding scheme for GSAs

Report provides overview of possibilities, challenges, and applications of next-generation sequencing

Case Challenges Patents as Dangerous Roadblock to Patient Care, Medical Innovation

The record-breaking number of abstract submissions for the AMP 2012 Annual Meeting on Genomic Medicine is consistent with the increased number of exhibiting companies and anticipated number of attendees.

Proposal to be completed by the end of June and released for feedback from stakeholders in the laboratory and payer community before submission of a formal proposal to the AMA CPT Editorial Panel.

The goal of the group is to produce a white paper that will outline the key issues, and provide AMP's recommendations for future LDT oversight.

AMP is optimistic that it will ultimately prevail in its lawsuit to invalidate patents on two genes that are known to cause breast cancer.

AMP is encouraged by the Court's recognition that Prometheus patents neither promote the advancement of medical practice, nor benefit patient care.

AMP testified at the U.S. Patent and Trademark Office hearing regarding patents on human genes.

AMP adopts change in governance structure as part of newly implemented strategic plan.